Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ando

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Communications Biology|May 25, 2022
Automated amplification-free digital RNA detection platform for rapid and sensitive SARS-CoV-2 diagnosisHajime Shinoda, Tatsuya Iida, Asami Makino, et al.
Annals of Hematology|March 10, 2025
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapySeiichiro Katagiri, Daigo Akahane, Kunihiko Takeyama, et al.
Haematologica|October 17, 2024
Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomasErina Hosoya, Jun Ando, Shintaro Kinoshita, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2021
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomaSakiko Harada, Miki Ando, Jun Ando, et al.
Cell Reports. Medicine|December 13, 2023
iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancerYoshiki Furukawa, Midori Ishii, Jun Ando, et al.
Stem Cell Reports|September 1, 2015
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell TherapyMiki Ando, Toshinobu Nishimura, Satoshi Yamazaki, et al.
International Journal of Hematology|June 9, 2026
TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trialKoji Izutsu, Ayumi Fujimoto, Shinya Rai, et al.
Cell Reports Methods|January 13, 2024
Identification of activity-based biomarkers for early-stage pancreatic tumors in blood using single-molecule enzyme activity screeningShingo Sakamoto, Hideto Hiraide, Mayano Minoda, et al.
Cytotherapy|August 21, 2012
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsNatalia Lapteva, April G Durett, Jiali Sun, et al.
Hematology (Amsterdam, Netherlands)|April 16, 2024
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in JapanYoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Communications Biology|May 25, 2022
Automated amplification-free digital RNA detection platform for rapid and sensitive SARS-CoV-2 diagnosisHajime Shinoda, Tatsuya Iida, Asami Makino, et al.
Annals of Hematology|March 10, 2025
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapySeiichiro Katagiri, Daigo Akahane, Kunihiko Takeyama, et al.
Haematologica|October 17, 2024
Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomasErina Hosoya, Jun Ando, Shintaro Kinoshita, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2021
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomaSakiko Harada, Miki Ando, Jun Ando, et al.
Cell Reports. Medicine|December 13, 2023
iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancerYoshiki Furukawa, Midori Ishii, Jun Ando, et al.
Stem Cell Reports|September 1, 2015
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell TherapyMiki Ando, Toshinobu Nishimura, Satoshi Yamazaki, et al.
International Journal of Hematology|June 9, 2026
TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trialKoji Izutsu, Ayumi Fujimoto, Shinya Rai, et al.
Cell Reports Methods|January 13, 2024
Identification of activity-based biomarkers for early-stage pancreatic tumors in blood using single-molecule enzyme activity screeningShingo Sakamoto, Hideto Hiraide, Mayano Minoda, et al.
Cytotherapy|August 21, 2012
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsNatalia Lapteva, April G Durett, Jiali Sun, et al.
Hematology (Amsterdam, Netherlands)|April 16, 2024
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in JapanYoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, et al.
Pageof 13